Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome

Detalhes bibliográficos
Autor(a) principal: Rauber, Mariana Reis
Data de Publicação: 2019
Outros Autores: Pilger, Diogo Andre, Cecconello, Daiane Keller, Falcetta, Frederico Soares, Marcondes, Natália Aydos, Faulhaber, Gustavo Adolpho Moreira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/196922
Resumo: Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.
id UFRGS-2_b8674916684c54e747fef5bee7251a93
oai_identifier_str oai:www.lume.ufrgs.br:10183/196922
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Rauber, Mariana ReisPilger, Diogo AndreCecconello, Daiane KellerFalcetta, Frederico SoaresMarcondes, Natália AydosFaulhaber, Gustavo Adolpho Moreira2019-07-13T02:36:12Z20190001-3765http://hdl.handle.net/10183/196922001095663Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.application/pdfengAnais da Academia Brasileira de Ciências. Rio de Janeiro, RJ. Vol. 91, n. 2 (2019), artigo e20180286HepcidinasSíndrome metabólicaFerritinasDiagnostic screeningFerritinHepcidinIronMetabolic syndromeHepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndromeinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001095663.pdf.txt001095663.pdf.txtExtracted Texttext/plain22656http://www.lume.ufrgs.br/bitstream/10183/196922/2/001095663.pdf.txt10096c6acf579b7ca4ea7909eeeef1a0MD52ORIGINAL001095663.pdfTexto completo (inglês)application/pdf835978http://www.lume.ufrgs.br/bitstream/10183/196922/1/001095663.pdf77443eeda50ebb6efd874277bc7e839fMD5110183/1969222019-07-14 02:37:09.858572oai:www.lume.ufrgs.br:10183/196922Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2019-07-14T05:37:09Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
spellingShingle Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
Rauber, Mariana Reis
Hepcidinas
Síndrome metabólica
Ferritinas
Diagnostic screening
Ferritin
Hepcidin
Iron
Metabolic syndrome
title_short Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_full Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_fullStr Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_full_unstemmed Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_sort Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
author Rauber, Mariana Reis
author_facet Rauber, Mariana Reis
Pilger, Diogo Andre
Cecconello, Daiane Keller
Falcetta, Frederico Soares
Marcondes, Natália Aydos
Faulhaber, Gustavo Adolpho Moreira
author_role author
author2 Pilger, Diogo Andre
Cecconello, Daiane Keller
Falcetta, Frederico Soares
Marcondes, Natália Aydos
Faulhaber, Gustavo Adolpho Moreira
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Rauber, Mariana Reis
Pilger, Diogo Andre
Cecconello, Daiane Keller
Falcetta, Frederico Soares
Marcondes, Natália Aydos
Faulhaber, Gustavo Adolpho Moreira
dc.subject.por.fl_str_mv Hepcidinas
Síndrome metabólica
Ferritinas
topic Hepcidinas
Síndrome metabólica
Ferritinas
Diagnostic screening
Ferritin
Hepcidin
Iron
Metabolic syndrome
dc.subject.eng.fl_str_mv Diagnostic screening
Ferritin
Hepcidin
Iron
Metabolic syndrome
description Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-07-13T02:36:12Z
dc.date.issued.fl_str_mv 2019
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/196922
dc.identifier.issn.pt_BR.fl_str_mv 0001-3765
dc.identifier.nrb.pt_BR.fl_str_mv 001095663
identifier_str_mv 0001-3765
001095663
url http://hdl.handle.net/10183/196922
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Anais da Academia Brasileira de Ciências. Rio de Janeiro, RJ. Vol. 91, n. 2 (2019), artigo e20180286
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/196922/2/001095663.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/196922/1/001095663.pdf
bitstream.checksum.fl_str_mv 10096c6acf579b7ca4ea7909eeeef1a0
77443eeda50ebb6efd874277bc7e839f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv lume@ufrgs.br
_version_ 1817725050636206080